CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Vyne Therapeutics Inc.

For profitWebsite ↗

Also known as: Acting Chief Medical Officer, Tigercat Pharma, Inc. | Menlo Therapeutics | Menlo Therapeutics Inc. | Tigercat Pharma, Inc. | VYNE | Vyne Therapeutics Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Oct 1, 2013

First marketed drug

Oct 18, 2019

Last known activity

Jun 4, 2024

Acquired by Foamix Ltd. on Nov 11, 2019

Timeline

2010s

  1. Jun 1, 2011

    Vyne Therapeutics Inc.— Founded

  2. Oct 18, 2019

    minocycline— Marketing Organization

  3. Nov 11, 2019

    Foamix Ltd.Foamix Ltd.— Acquired By

Drugs by trial phase (6 distinct, 15 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (16)

Details

Founded
Menlo Park, CA, US Jun 1, 2011
Last known activity
Jun 4, 2024